Literature DB >> 28084098

MTNR1A and MTNR1B gene polymorphisms in women with gestational diabetes.

Maciej Tarnowski1, Damian Malinowski1, Krzysztof Safranow2, Violetta Dziedziejko2, Andrzej Pawlik1.   

Abstract

Gestational diabetes mellitus (GDM) is glucose intolerance detected during pregnancy. The MTNR1B gene is the genetic locus associated with type 2 diabetes, that may affect insulin secretion and pancreatic glucose sensing. In this study, we examined the association between MTNR1A (rs2119882) and MTNR1B (rs10830963, rs4753426) gene polymorphisms and the risk of GDM. According to the results of their oral glucose tolerance test (OGTT), the women were divided into two groups: 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). There were no statistically significant differences in the distribution of MTNR1A rs2119882 and MTNR1B rs4753426 genotypes and alleles between women with GDM and healthy pregnant women. With regard to the MTNR1B rs10830963 polymorphism, we observed a statistically significant prevalence of GG and CG genotypes and the G allele among pregnant women with GDM (GG + CG vs CC, OR 1.50, 95% CI 1.02-2.22, p = 0.04; G vs C, OR 1.43, 95% CI 1.07-1.90, p = 0.016). In a multivariate logistic regression analysis, a higher number of MTNR1B rs10830963 G alleles was an independent significant predictor of a higher risk of GDM. The results of our study indicate that MTNR1B rs10830963 polymorphism is associated with GDM susceptibility, and women with a higher number of G alleles have an increased risk of GDM development.

Entities:  

Keywords:  Gestational diabetes; melatonin receptors; polymorphisms

Mesh:

Substances:

Year:  2017        PMID: 28084098     DOI: 10.1080/09513590.2016.1276556

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  10 in total

Review 1.  Melatonin, mitochondria, and the metabolic syndrome.

Authors:  Daniel P Cardinali; Daniel E Vigo
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

Review 2.  Ethnic Disparities in Gestational Diabetes.

Authors:  Lili Yuen; Vincent W Wong; David Simmons
Journal:  Curr Diab Rep       Date:  2018-07-23       Impact factor: 4.810

3.  Genetic determinants of gestational diabetes mellitus: a case-control study in two independent populations.

Authors:  Yi Shen; Yulong Jia; Yuandong Li; Xuefeng Gu; Guoqing Wan; Peng Zhang; Yafeng Zhang; Liying Jiang
Journal:  Acta Diabetol       Date:  2020-02-29       Impact factor: 4.280

Review 4.  Molecular Biomarkers for Gestational Diabetes Mellitus.

Authors:  Stephanie Dias; Carmen Pheiffer; Yoonus Abrahams; Paul Rheeder; Sumaiya Adam
Journal:  Int J Mol Sci       Date:  2018-09-26       Impact factor: 5.923

Review 5.  Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease.

Authors:  Georgi Nikolaev; Ralitsa Robeva; Rossitza Konakchieva
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

6.  MTNR1B polymorphisms with CDKN2A and MGMT methylation status are associated with poor prognosis of colorectal cancer in Taiwan.

Authors:  Chia-Cheng Lee; Yu-Cheng Kuo; Je-Ming Hu; Pi-Kai Chang; Chien-An Sun; Tsan Yang; Chuan-Wang Li; Chao-Yang Chen; Fu-Huang Lin; Chih-Hsiung Hsu; Yu-Ching Chou
Journal:  World J Gastroenterol       Date:  2021-09-14       Impact factor: 5.742

7.  Melatonin Receptor 1B Genetic Variants on Susceptibility to Gestational Diabetes Mellitus: A Hospital-Based Case-Control Study in Wuhan, Central China.

Authors:  Jianqiong Liu; Wei Li; Bei Liu; Anna Dai; Yanqin Wang; Lu She; Pei Zhang; Wenpei Zheng; Qiong Dai; Mei Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-20       Impact factor: 3.249

8.  Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma.

Authors:  Shih-Chi Su; Yung-Chuan Ho; Yu-Fan Liu; Russel J Reiter; Chia-Hsuan Chou; Chia-Ming Yeh; Hsiang-Lin Lee; Wen-Hung Chung; Ming-Ju Hsieh; Shun-Fa Yang
Journal:  Oncotarget       Date:  2017-09-20

Review 9.  The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Authors:  Eduardo Spinedi; Daniel P Cardinali
Journal:  Int J Endocrinol       Date:  2018-07-25       Impact factor: 3.257

10.  MTNR1B genetic polymorphisms as risk factors for gestational diabetes mellitus: a case-control study in a single tertiary care center.

Authors:  Khalid Khalaf Alharbi; Abdulrahman Mohammed Al-Sulaiman; Khalid Muath Bin Shedaid; Ali M Al-Shangiti; Mohammed Marie; Yazeed A Al-Sheikh; Imran Ali Khan
Journal:  Ann Saudi Med       Date:  2019-10-03       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.